FDA employees consider how to handle RFK Jr., including leaving from

FDA Employees Float Plan to Deal With Ex-Prosecutor Kennedy

The agency is reportedly weighing its options, including the possibility of reassigning or even firing him.

Robert F. Kennedy Jr., a vocal critic of vaccines, has been a thorn in the side of the Food and Drug Administration for years. Now, agency employees are reportedly discussing how to deal with him, including the possibility of reassigning or even firing him.

Kennedy, the son of Robert F. Kennedy and nephew of President John F. Kennedy, has been a vocal critic of vaccines for years, claiming that they are dangerous and ineffective.

In recent months, Kennedy has stepped up his attacks on the FDA, accusing the agency of being corrupt and in cahoots with the pharmaceutical industry.

The FDA has tried to ignore Kennedy's attacks, but they have become increasingly difficult to ignore. In recent weeks, Kennedy has given several high-profile speeches in which he has repeated his claims about vaccines.

Now, FDA employees are reportedly discussing how to deal with Kennedy. One option is to reassign him to a different position within the agency. Another option is to fire him.

Firing Kennedy would be a controversial move, but it may be necessary if the FDA wants to restore its credibility.

Kennedy has been a vocal critic of vaccines for years.
In recent months, Kennedy has stepped up his attacks on the FDA.
The FDA is reportedly discussing how to deal with Kennedy, including the possibility of reassigning or even firing him.
Firing Kennedy would be a controversial move, but it may be necessary if the FDA wants to restore its credibility.